Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A19943 | 26251667 | Nutr Metab (Lond) | Exercise training improves liver steatosis in mice. | 2015 | Details |
| A19944 | 26251217 | J Gastroenterol Hepatol | The increasing burden of potentially preventable liver disease among adult liver transplant recipients: A comparative analysis of liver transplant indication by era in Australia and New Zealand. | 2016 | Details |
| A19945 | 26250831 | Dig Dis Sci | Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience. | 2015 | Details |
| A19946 | 26250597 | J Sci Food Agric | Anthocyanin-rich extracts from blackberry, wild blueberry, strawberry, and chokeberry: antioxidant activity and inhibitory effect on oleic acid-induced hepatic steatosis in vitro. | 2015 | Details |
| A19947 | 26250514 | Obesity (Silver Spring) | Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. | 2015 | Details |
| A19948 | 26247669 | Clinics (Sao Paulo) | Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: a ten-year retrospective study. | 2015 | Details |
| A19949 | 26246326 | J Nutr | Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. | 2015 | Details |
| A19950 | 26246323 | J Nutr | Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats. | 2015 | Details |
| A19951 | 26244718 | J Investig Med | Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology. | 2015 | Details |
| A19952 | 26244072 | Nutr Res Pract | Characteristics of nonalcoholic fatty liver disease induced in wistar rats following four different diets. | 2015 | Details |
| A19953 | 26242978 | Lipids Health Dis | Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats. | 2015 | Details |
| A19954 | 26242295 | Trials | The link between obesity and vitamin D in bariatric patients with omega-loop gastric bypass surgery - a vitamin D supplementation trial to compare the efficacy of postoperative cholecalciferol loading (LOAD): study protocol for a randomized controlled trial. | 2015 | Details |
| A19955 | 26242257 | Curr Med Chem | Flavonoids and Related Compounds in Non-Alcoholic Fatty Liver Disease Therapy. | 2015 | Details |
| A19956 | 26242131 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [The New Idea about Early Intervention for Type 2 Diabetes Based on Gan Disease Transferring to Pi in Metabolic Diseases]. | 2015 | Details |
| A19957 | 26241028 | J Steroid Biochem Mol Biol | Glucocorticoids and non-alcoholic fatty liver disease. | 2015 | Details |
| A19958 | 26240695 | World J Diabetes | Metabolic surgery: A paradigm shift in type 2 diabetes management. | 2015 | Details |
| A19959 | 26240153 | J Biol Chem | Sphingosine Kinase 1 Protects Hepatocytes from Lipotoxicity via Down-regulation of IRE1α Protein Expression. | 2015 | Details |
| A19961 | 26239844 | BMC Gastroenterol | Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis. | 2015 | Details |
| A19966 | 26235878 | Biochem Biophys Res Commun | The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver. | 2015 | Details |
| A19967 | 26234727 | Metabolism | Nonalcoholic fatty liver disease and statins. | 2015 | Details |
| A19968 | 26234526 | Br J Nutr | The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. | 2015 | Details |
| A19969 | 26234231 | Intern Med | Hepatocellular Carcinoma in a Patient with Polycystic Liver Disease. | 2015 | Details |
| A19970 | 26233911 | Adv Pharmacol | Translational Implications of the Alcohol-Metabolizing Enzymes, Including Cytochrome P450-2E1, in Alcoholic and Nonalcoholic Liver Disease. | 2015 | Details |
| A19971 | 26233836 | Pharmacoeconomics | Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease. | 2015 | Details |
| A19972 | 26233687 | Arch Toxicol | RNAi in murine hepatocytes: the agony of choice--a study of the influence of lipid-based transfection reagents on hepatocyte metabolism. | 2015 | Details |
| A19973 | 26232233 | Am J Physiol Heart Circ Physiol | Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. | 2015 | Details |
| A19974 | 26231377 | Drug Metab Dispos | CYP3A Activity and Expression in Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19975 | 26229968 | J Diabetes Res | Rat Models of Diet-Induced Obesity and High Fat/Low Dose Streptozotocin Type 2 Diabetes: Effect of Reversal of High Fat Diet Compared to Treatment with Enalapril or Menhaden Oil on Glucose Utilization and Neuropathic Endpoints. | 2015 | Details |
| A19976 | 26229402 | World J Gastroenterol | Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B. | 2015 | Details |
| A19977 | 26229237 | Mediators Inflamm | CD4+ROR γ t++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis. | 2015 | Details |
| A19978 | 26228676 | J Clin Lipidol | Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease. | 2015 | Details |
| A19980 | 26228367 | Saudi J Gastroenterol | Nonalcoholic fatty liver disease progression in rats is accelerated by splenic regulation of liver PTEN/AKT. | 2016 | Details |
| A19981 | 26228038 | Lipids Health Dis | Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds. | 2015 | Details |
| A19982 | 26226139 | PLoS One | Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial. | 2015 | Details |
| A19983 | 26226099 | Clin Gastroenterol Hepatol | Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19984 | 26226097 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. | 2015 | Details |
| A19985 | 26226095 | Clin Gastroenterol Hepatol | Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis. | 2015 | Details |
| A19986 | 26224591 | Hepatology | Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. | 2015 | Details |
| A19987 | 26224399 | Expert Rev Gastroenterol Hepatol | Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. | 2015 | Details |
| A19988 | 26223319 | Free Radic Res | Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. | 2015 | Details |
| A19989 | 26221316 | Int J Clin Exp Med | Association between nonalcoholic fatty liver disease and carotid atherosclerosis: a meta-analysis. | 2015 | Details |
| A19990 | 26221297 | Int J Clin Exp Med | Berberine reverses abnormal expression of L-type pyruvate kinase by DNA demethylation and histone acetylation in the livers of the non-alcoholic fatty disease rat. | 2015 | Details |
| A19991 | 26221176 | Evid Based Complement Alternat Med | Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A19992 | 26219858 | Mayo Clin Proc | Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2015 | Details |
| A19993 | 26219393 | Curr Med Chem | The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular). | 2015 | Details |
| A19994 | 26216400 | J Proteome Res | Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome. | 2015 | Details |
| A19995 | 26216030 | Clin Res Hepatol Gastroenterol | Inflammasome activation in the liver: Focus on alcoholic and non-alcoholic steatohepatitis. | 2015 | Details |
| A19996 | 26215699 | J Pharmacol Sci | JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis. | 2015 | Details |
| A19997 | 26215532 | Am J Gastroenterol | Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. | 2015 | Details |
| A19998 | 26215420 | Biomed Khim | [Intensity of apoptotic processes, aconitate hydratase activity and citrate level in patients with type 2 diabetes mellitus complicated steatohepatitis under application of epifamin at basic therapy]. | 2016 | Details |
| A19999 | 26215323 | BMC Gastroenterol | Associations of coffee consumption with markers of liver injury in the insulin resistance atherosclerosis study. | 2015 | Details |
| A20000 | 26215259 | Nat Rev Endocrinol | Physiological and pathophysiological roles of NAMPT and NAD metabolism. | 2015 | Details |
| A20001 | 26215061 | Turk J Gastroenterol | The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters. | 2015 | Details |
| A20002 | 26215060 | Turk J Gastroenterol | Increased plasma CgA levels associated with nonalcoholic fatty liver disease. | 2015 | Details |
| A20003 | 26214605 | Obes Rev | Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization. | 2015 | Details |
| A20004 | 26214582 | Lab Invest | Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression. | 2015 | Details |
| A20005 | 26214517 | PLoS One | PDIA3 Knockdown Exacerbates Free Fatty Acid-Induced Hepatocyte Steatosis and Apoptosis. | 2015 | Details |
| A20006 | 26212089 | J Gastroenterol Hepatol | Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease. | 2016 | Details |
| A20007 | 26211668 | Endocr J | A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease. | 2015 | Details |
| A20008 | 26207852 | J Agric Food Chem | Inhibition of Advanced Glycation Endproduct Formation by Lotus Seedpod Oligomeric Procyanidins through RAGE-MAPK Signaling and NF-κB Activation in High-Fat-Diet Rats. | 2015 | Details |
| A20012 | 26205992 | Abdom Imaging | Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease. | 2015 | Details |
| A20013 | 26204635 | Rev Med Chir Soc Med Nat Iasi | NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMPLICATIONS--ASSESSING THE POPULATION AT RISK. A SMALL SERIES REPORT AND LITERATURE REVIEW. | 2015 | Details |
| A20014 | 26203862 | Cell Death Dis | Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. | 2015 | Details |
| A20015 | 26203597 | Curr Opin Clin Nutr Metab Care | Fructose and liver function--is this behind nonalcoholic liver disease? | 2015 | Details |
| A20016 | 26203576 | Rev Med Chil | [Second Consensus of the Chilean Society of Endocrinology and Diabetes about insulin resistance]. | 2015 | Details |
| A20017 | 26203166 | J Endocrinol | Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21. | 2015 | Details |
| A20018 | 26202818 | Aliment Pharmacol Ther | Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study. | 2015 | Details |
| A20019 | 26202539 | Br J Nutr | Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study. | 2015 | Details |
| A20020 | 26202197 | Mini Rev Med Chem | Creatine and the Liver: Metabolism and Possible Interactions. | 2016 | Details |
| A20021 | 26202098 | Cardiovasc Ther | Nonalcoholic Steatohepatitis Score is an Independent Predictor of Right Ventricular Dysfunction in Patients with Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20022 | 26201937 | Clin Endocrinol (Oxf) | Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. | 2015 | Details |
| A20023 | 26201461 | Drugs | Non-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval Pathway. | 2015 | Details |
| A20024 | 26201284 | J Magn Reson Imaging | Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. | 2015 | Details |
| A20025 | 26201023 | Clin Sci (Lond) | Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. | 2015 | Details |
| A20026 | 26200917 | Chem Phys Lipids | In vivo proton magnetic resonance spectroscopy of liver metabolites in non-alcoholic fatty liver disease in rats: T2 relaxation times in methylene protons. | 2015 | Details |
| A20027 | 26200108 | PLoS One | Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects. | 2015 | Details |
| A20028 | 26200028 | Rev Esp Quimioter | Maraviroc modifies gut microbiota composition in a mouse model of obesity: a plausible therapeutic option to prevent metabolic disorders in HIV-infected patients. | 2015 | Details |
| A20029 | 26199862 | FEBS Open Bio | 2D DIGE proteomic analysis highlights delayed postnatal repression of α-fetoprotein expression in homocystinuria model mice. | 2015 | Details |
| A20030 | 26199227 | J Am Heart Assoc | Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population. | 2015 | Details |
| A20031 | 26199205 | Hepatology | A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers. | 2015 | Details |
| A20032 | 26198953 | Nan Fang Yi Ke Da Xue Xue Bao | [Association between polymorphisms in pigment epithelium-derived factor gene promoter region and non-alcoholic fatty liver disease in type 2 diabetes mellitus]. | 2015 | Details |
| A20033 | 26198758 | Hepatol Int | Effect of metformin treatment on circulating osteoprotegerin in patients with nonalcoholic fatty liver disease. | 2015 | Details |
| A20034 | 26198708 | Wiley Interdiscip Rev RNA | 'Micro-managers' of hepatic lipid metabolism and NAFLD. | 2015 | Details |
| A20035 | 26197341 | Biomolecules | Roles of Chemokines and Chemokine Receptors in Obesity-Associated Insulin Resistance and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20036 | 26197019 | Anal Chem | Solutions for low and high accuracy mass spectrometric data matching: a data-driven annotation strategy in nontargeted metabolomics. | 2015 | Details |
| A20037 | 26196445 | Clin Gastroenterol Hepatol | Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20038 | 26195184 | Expert Opin Biol Ther | Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study. | 2015 | Details |
| A20039 | 26194602 | Liver Transpl | Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients. | 2015 | Details |
| A20040 | 26194256 | Surg Endosc | Non-alcoholic fatty liver disease resolution following sleeve gastrectomy. | 2015 | Details |
| A20041 | 26194065 | Cytokine | PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats. | 2015 | Details |
| A20042 | 26193881 | Lipids Health Dis | Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice. | 2015 | Details |
| A20043 | 26193757 | Int J Urol | Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review. | 2015 | Details |
| A20044 | 26193052 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease and carotid artery atherosclerosis in children and adults: a meta-analysis. | 2015 | Details |
| A20045 | 26193051 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease-related cardiovascular risk: Is there an association with blood hemoglobin levels? | 2015 | Details |
| A20046 | 26192240 | Zhonghua Gan Zang Bing Za Zhi | [A prospective study of serum fibroblast growth factor 21 changes in nonalcoholic fatty liver patients]. | 2015 | Details |
| A20047 | 26192239 | Zhonghua Gan Zang Bing Za Zhi | [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients]. | 2015 | Details |
| A20048 | 26191473 | Springerplus | Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury. | 2015 | Details |
| A20049 | 26191218 | Int J Clin Exp Pathol | Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function. | 2015 | Details |
| A20050 | 26190559 | Food Funct | Modulation of tissue fatty acids by L-carnitine attenuates metabolic syndrome in diet-induced obese rats. | 2015 | Details |
| A20051 | 26190501 | J Gastroenterol | Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis. | 2015 | Details |